Omeprazol Neuraxpharm (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Neuraxpharm, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is used to manage conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease and as part of Helicobacter pylori eradication regimens.

GNH USA supplies Omeprazol Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers.

Omeprazole, a proton pump inhibitor, acts on the gastric acid secretion pathway to treat several acid‑related disorders.

- Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of the esophageal lining. - Erosive esophagitis: facilitates mucosal repair by decreasing acid exposure. - Peptic ulcer disease: supports ulcer healing and prevents recurrence by maintaining a higher gastric pH. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotics by creating a less acidic gastric environment.

Omeprazole may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate head pain that may resolve spontaneously. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of queasiness, sometimes leading to vomiting. - Diarrhea: loose, frequent stools that are usually self‑limiting.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rapid onset of hives, swelling, breathing difficulty. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea and abdominal pain. - Low magnesium levels (hypomagnesemia): muscle weakness, tremors, or cardiac arrhythmias.

When prescribing Omeprazole, several precautionary measures should be considered to ensure safe use.

- Assess renal function: dose adjustment may be required in patients with severe renal impairment. - Monitor magnesium levels: prolonged therapy can lead to hypomagnesemia, requiring periodic testing. - Use caution in liver disease: hepatic impairment may affect drug metabolism and should be monitored. - Limit long‑term use: extended therapy without supervision may increase risk of nutrient deficiencies and bone fractures. - Store at ambient temperature: keep in the original packaging, protect from moisture and light.

Omeprazole can affect the pharmacokinetics of several concomitant medicines, leading to clinically relevant interactions.

Major Interactions (Avoid): - Ketoconazole: reduced absorption and efficacy of ketoconazole when gastric pH is increased. - Atazanavir: decreased plasma concentrations of atazanavir, compromising antiviral activity. - Clopidogrel: impaired activation of clopidogrel, potentially reducing antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer coagulation monitoring. - Digoxin: higher serum digoxin levels may occur, necessitating dose adjustment. - Methotrexate: increased risk of toxicity due to reduced renal clearance.